Brief: Axovant Gene Therapies Gave Notice To Voluntarily Prepay Amount Equal To $16 Mln, Under Loan And Security Agreement, Dated Feb 2, 2017
April 20 (Reuters) - Axovant Gene Therapies Ltd AXGT.O :
* AXOVANT GENE THERAPIES - ON APRIL 14, GAVE NOTICE TO
VOLUNTARILY PREPAY AMOUNT EQUAL TO $16 MILLION, UNDER LOAN AND
SECURITY AGREEMENT, DATED FEB 2, 2017
* AXOVANT GENE THERAPIES LTD - IN ADDITION, TO PAY HERCULES
CAPITAL, CHARGE EQUAL TO 1.0% OF OUTSTANDING PRINCIPAL, OR ABOUT
$157,000
Source text: [https://bit.ly/2VKHheH]
Further company coverage: AXGT.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results